227 related articles for article (PubMed ID: 26350106)
1. Curcumin Nanoparticles Attenuate Production of Pro-inflammatory Markers in Lipopolysaccharide-Induced Macrophages.
Lee WH; Loo CY; Young PM; Rohanizadeh R; Traini D
Pharm Res; 2016 Feb; 33(2):315-27. PubMed ID: 26350106
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway.
Wang J; Zhu R; Sun D; Sun X; Geng Z; Liu H; Wang SL
J Biomed Nanotechnol; 2015 Mar; 11(3):403-15. PubMed ID: 26307824
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
[TBL] [Abstract][Full Text] [Related]
4. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of curcumin nanoparticles towards alveolar macrophage: Effects of surface charges.
Loo CY; Siew EL; Young PM; Traini D; Lee WH
Food Chem Toxicol; 2022 May; 163():112976. PubMed ID: 35364129
[TBL] [Abstract][Full Text] [Related]
6. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
7. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of monooleine aqueous dispersions as tools for topical administration of curcumin: characterization, in vitro and ex-vivo studies.
Puglia C; Cardile V; Panico AM; Crascì L; Offerta A; Caggia S; Drechsler M; Mariani P; Cortesi R; Esposito E
J Pharm Sci; 2013 Jul; 102(7):2349-61. PubMed ID: 23686742
[TBL] [Abstract][Full Text] [Related]
9. Nanocarrier with self-antioxidative property for stabilizing and delivering ascorbyl palmitate into skin.
Janesirisakule S; Sinthusake T; Wanichwecharungruang S
J Pharm Sci; 2013 Aug; 102(8):2770-9. PubMed ID: 23775704
[TBL] [Abstract][Full Text] [Related]
10. Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophages.
Andreasen SØ; Chong SF; Wohl BM; Goldie KN; Zelikin AN
Biomacromolecules; 2013 May; 14(5):1687-95. PubMed ID: 23560438
[TBL] [Abstract][Full Text] [Related]
11. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
Lee WH; Loo CY; Rohanizadeh R
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
[TBL] [Abstract][Full Text] [Related]
12. Combined delivery of curcumin and the heme oxygenase-1 gene using cholesterol-conjugated polyamidoamine for anti-inflammatory therapy in acute lung injury.
Kim G; Piao C; Oh J; Lee M
Phytomedicine; 2019 Mar; 56():165-174. PubMed ID: 30668337
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity.
Lee WH; Bebawy M; Loo CY; Luk F; Mason RS; Rohanizadeh R
J Biomed Nanotechnol; 2015 Jun; 11(6):1093-105. PubMed ID: 26353597
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis.
Wang J; Wang H; Zhu R; Liu Q; Fei J; Wang S
Biomaterials; 2015; 53():475-83. PubMed ID: 25890744
[TBL] [Abstract][Full Text] [Related]
16. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
17. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
18. Curcumin‑loaded PEG‑PDLLA nanoparticles for attenuating palmitate‑induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway.
Zhang J; Wang Y; Bao C; Liu T; Li S; Huang J; Wan Y; Li J
Int J Mol Med; 2019 Aug; 44(2):672-682. PubMed ID: 31173176
[TBL] [Abstract][Full Text] [Related]
19. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Chaubey P; Mishra B; Mudavath SL; Patel RR; Chaurasia S; Sundar S; Suvarna V; Monteiro M
Int J Biol Macromol; 2018 May; 111():109-120. PubMed ID: 29307805
[TBL] [Abstract][Full Text] [Related]
20. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]